Treco James, a director at Tonix Pharmaceuticals Holding Corp. ($TNXP), made one open market purchase of shares in the past year, totaling $9,000. His most recent buy occurred on August 20, 2025. These TNXP insider purchases rank 4,381st among 4,983 individuals in our database, where the average is about $1.5 million across 3.3 transactions. Treco James reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 20, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | Treco James | Director | P | Common Stock, par value $0.001 | 250 | $36.00 | 250.0000 | 5,590,667 | 9999.99% | 0.00% |
| May 13, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | Treco James | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 5,590,667 | 9999.99% | 0.18% |
| Feb. 5, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | Treco James | Director | J | Common Stock, par value $0.001 | 0 | $0.30 | 0.0000 | 559,044,486 | 100.00% | 0.00% |
| May 23, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | Treco James | Director | A | Stock Option | 104621 | $0.00 | 104,621.0000 | 20,926 | 9999.99% | 100.00% |